Discovering New Tyrosinase Inhibitors by Using In Silico Modelling, Molecular Docking, and Molecular Dynamics

Discovering New Tyrosinase Inhibitors by Using In Silico Modelling, Molecular Docking, and Molecular Dynamics

<b>Background/Objectives:</b> This study was used in silico modelling to search for potential tyrosinase protein inhibitors from a database of different core structures for IC<sub>50</sub> prediction. <b>Methods</b>: Four machine learning algorithms and topographi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kevin A. OréMaldonado, Sebastián A. Cuesta, José R. Mora, Marcos A. Loroño, José L. Paz
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Pharmaceuticals
Subjects:	tyrosinase melanoma QSAR molecular docking molecular dynamics
Online Access:	https://www.mdpi.com/1424-8247/18/3/418
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anilino-1,4-naphthoquinones as potent mushroom tyrosinase inhibitors: in vitro and in silico studies
by: Sahachai Sabuakham, et al.
Published: (2024-12-01)

Discovery of bis-thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study
by: Sahachai Sabuakham, et al.
Published: (2025-12-01)

SMILES-based QSAR and molecular docking studies of chalcone analogues as potential anti-colon cancer
by: Abolfazl Askarzade, et al.
Published: (2025-02-01)

Exploring QSAR, molecular docking, molecular dynamics and pharmacokinetics for 3,4-Dihydro-2H,6H-pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives targeting Plasmodium falciparum dihydroorotate dehydrogenase
by: Naveen Dhingra, et al.
Published: (2025-05-01)

In Silico Screening Studies on Methanesulfonamide Derivatives as Dual Hsp27 and Tubulin Inhibitors Using QSAR and Molecular Docking
by: A. Mostoufi, et al.
Published: (2018-09-01)

Antioxidant, Anti-α-Glucosidase, Anti-Tyrosinase, and Anti-Acetylcholinesterase Components from Stem of <i>Rhamnus formosana</i> with Molecular Docking Study
by: Chia-Hsuan Tsai, et al.
Published: (2024-12-01)

Silybin Derivatives Produced by γ-Irradiation and Their Tyrosinase Inhibitory Activities
by: Ah-Reum Han, et al.
Published: (2024-11-01)

2D-QSAR driven design, molecular docking, molecular dynamics simulation and MM/GBSA studies on quinazoline derivatives for development of VEGFR-2 inhibitors
by: Mayank Kashyap, et al.
Published: (2025-05-01)

ANN-QSAR, Molecular Docking, ADMET Predictions, and Molecular Dynamics Studies of Isothiazole Derivatives to Design New and Selective Inhibitors of HCV Polymerase NS5B
by: Maroua Fattouche, et al.
Published: (2024-12-01)

Cheminformatics approaches to predict the bioactivity and to discover the pharmacophoric traits crucial to block NF-κB
by: Rahul D. Jawarkar, et al.
Published: (2024-12-01)

Inhibitory mechanism on tyrosinase activity of flavonoids from flower buds of Sophora japonica L
by: Yunfeng Ma, et al.
Published: (2024-10-01)

Development of mercapto-phenyl-1,2,4-triazole bearing thio-quinoline as a novel class of tyrosinase inhibitors: an in vitro and in silico study
by: Nazanin Motamedi Shakib, et al.
Published: (2025-07-01)

In silico design of novel pyridazine derivatives as balanced multifunctional agents against Alzheimer’s disease
by: Mourad Aloui, et al.
Published: (2025-05-01)

In Silico Evaluation of Potential NDM-1 Inhibitors: An Integrated Docking and Molecular Dynamics Approach
by: Eduvan Valencia, et al.
Published: (2024-12-01)

In silico design of novel dihydropteridone derivatives with oxadiazoles as potent inhibitors of MCF-7 breast cancer cells
by: Mourad Aloui, et al.
Published: (2025-07-01)

Tyrosinase inhibitors as melanoma sensitizers: Boosting therapeutic efficacy
by: Yongsheng Li, et al.
Published: (2025-12-01)

Synthesis and In Silico Evaluation of GABA, Pregabalin and Baclofen <i>N</i>-Heterocyclic Analogues as GABA<sub>B</sub> Receptor Agonists
by: Zuleyma Martínez-Campos, et al.
Published: (2025-03-01)

Drug design of an anticancer drug: QSAR modeling, and molecular docking
by: Sedigheh Aghayari
Published: (2025-09-01)

Molecular Docking Kaempferol sebagai Antiinflamasi pada Aterosklerosis secara In Silico
by: Gede Ngurah Hadi Candra, et al.
Published: (2021-03-01)

5-(2-Carboxyethenyl)-Isatin Derivatives as Anticancer Agents: QSAR, Molecular Docking and Molecular Dynamic Simulation Analysis
by: Leila Emami, et al.
Published: (2021-05-01)

Assessment of Anti-tyrosinase and Antioxidant Activities along with Molecular Docking Studies, and in silico ADME of Some 3-Hydroxypyridin-4-one Derivatives
by: Fateme Zare, et al.
Published: (2024-09-01)

Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells
by: Rong Huang, et al.
Published: (2025-05-01)

Phytochemical Investigation and Biological Activities of <i>Desmodium heterocarpon</i> Extract as Anti-Tyrosinase: Isolation of Natural Compounds, <i>In Vitro</i> and <i>In Silico</i> Study
by: Suthinee Sangkanu, et al.
Published: (2024-10-01)

Drug repurposing targeting COVID-19 3CL protease using molecular docking and machine learning regression approaches
by: Imra Aqeel, et al.
Published: (2025-05-01)

In Silico discovery of novel androgen receptor inhibitors for prostate cancer therapy using virtual screening, molecular docking, and molecular dynamics simulations
by: Xing Huang, et al.
Published: (2025-08-01)

The potential of Curcuma longa L. bioactive compounds as RSK inhibitors for the treatment of prostate cancer: in silico study
by: Olusola Olalekan Elekofehinti, et al.
Published: (2025-01-01)

Unveiling the Molecular Mechanisms Behind the Devastating Impact of the ALK Protein on Pediatric Cancers: Insights into Deleterious SNPs through In Silico Predictions, Molecular Docking, and Dynamics Studies
by: Abdulhadi Almazroea
Published: (2024-02-01)

Studying molecular interactions of synthetic glucocorticoids with TRPM8 by molecular docking
by: P. D. Timkin, et al.
Published: (2025-01-01)

Synthesis, Characterization, Molecular Docking, and In Silico ADME Study for Some New Different Derivatives for Succiniohydrazide
by: Asmaa A. Maryoosh, et al.
Published: (2025-01-01)

Molecular Docking: Methodological Approaches of Risk Assessment
by: A. Kh. Taldaev, et al.
Published: (2023-05-01)

Design and screening of novel 1,2,4-Triazole-3-thione derivatives as DCN1 inhibitors for anticardiac fibrosis based on 3D-QSAR modeling and molecular dynamics
by: Wengong Bian, et al.
Published: (2025-06-01)

Assessing molecular docking tools: understanding drug discovery and design
by: Harendar Kumar Nivatya, et al.
Published: (2025-08-01)

Phytochemical profiling and in silico evaluation of Artemisia absinthium compounds targeting Leishmania N-myristoyltransferase: molecular docking, drug-likeness, and toxicity analyses
by: Farouk Boudou, et al.
Published: (2024-11-01)

Rational design of novel phenol ether derivatives as non-covalent proteasome inhibitors through 3D-QSAR, molecular docking and ADMET prediction
by: Miao Yuan, et al.
Published: (2023-12-01)

Understanding molecular level properties of N(n-butyl)-N′-[p-chlorophenoxy) acetyl]urea by density functional, molecular docking and molecular dynamics computations
by: J. Sunil, et al.
Published: (2025-07-01)

<i>In Silico</i> Assessment of Enaminone–Sulfanilamides as Potential Carbonic Anhydrase II Inhibitors: Molecular Docking and ADMET Prediction
by: Yousra Ouafa Bouone, et al.
Published: (2024-11-01)

Design and evaluation of novel triazole derivatives as potential anti-gout inhibitors: a comprehensive molecular modeling study
by: Mohammed Er-rajy, et al.
Published: (2025-03-01)

An Activity of Flavonoid Derived Compounds from Medinilla speciosa Extract as Anti-hyperpigmentation against Tyrosinease Proteins with In Silico Methods
by: elshinta riantica, et al.
Published: (2024-05-01)

In Silico study of PDE10A inhibitors for schizophrenia: molecular docking, ADMET and DFT analysis
by: Ashutosh Kharwar, et al.
Published: (2025-06-01)

Discovering the inhibition of YAP/TEAD Hippo signaling pathway via new pyrazolone derivatives: synthesis, molecular docking and biological investigations
by: Ahmed A. Noser, et al.
Published: (2024-11-01)